DELCATH SYSTEMS INC
10-Q, EX-27, 2000-12-04
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: DELCATH SYSTEMS INC, 10-Q, 2000-12-04
Next: OPHIDIAN PHARMACEUTICALS INC, 8-K, 2000-12-04



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S SEPTEMBER 30, 2000 FORM 10-QSB AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                                    <C>

<PERIOD-TYPE>                          9-MOS
<FISCAL-YEAR-END>                                           DEC-31-2000
<PERIOD-END>                                                SEP-30-2000
<CASH>                                                          453,344
<SECURITIES>                                                          0
<RECEIVABLES>                                                         0
<ALLOWANCES>                                                          0
<INVENTORY>                                                           0
<CURRENT-ASSETS>                                              1,007,310
<PP&E>                                                           16,500
<DEPRECIATION>                                                   10,500
<TOTAL-ASSETS>                                                1,037,310
<CURRENT-LIABILITIES>                                           593,710
<BONDS>                                                               0
<COMMON>                                                         10,941
                                                 0
                                                      24,167
<OTHER-SE>                                                      408,492
<TOTAL-LIABILITY-AND-EQUITY>                                  1,037,310
<SALES>                                                               0
<TOTAL-REVENUES>                                                      0
<CGS>                                                                 0
<TOTAL-COSTS>                                                   560,953
<OTHER-EXPENSES>                                                      0
<LOSS-PROVISION>                                                      0
<INTEREST-EXPENSE>                                                4,270
<INCOME-PRETAX>                                                (546,298)
<INCOME-TAX>                                                          0
<INCOME-CONTINUING>                                            (546,298)
<DISCONTINUED>                                                        0
<EXTRAORDINARY>                                                       0
<CHANGES>                                                             0
<NET-INCOME>                                                   (546,298)
<EPS-BASIC>                                                       (0.54)
<EPS-DILUTED>                                                     (0.54)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission